

[ Wed, Jun 05th 2024
] - WOPRAI
[ Wed, Jun 05th 2024
] - WOPRAI
[ Wed, Jun 05th 2024
] - WOPRAI
[ Wed, Jun 05th 2024
] - WOPRAI
[ Wed, Jun 05th 2024
] - WOPRAI
[ Wed, Jun 05th 2024
] - WOPRAI
[ Wed, Jun 05th 2024
] - WOPRAI

[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
[ Tue, Jun 04th 2024
] - WOPRAI
Brian Abrahams Reiterated (VRTX) at Hold and Held Target at $424 on, Jun 4th, 2024
Brian Abrahams of RBC Capital, Reiterated "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold and Held Target at $424 on, Jun 4th, 2024.
Brian has made no other calls on VRTX in the last 4 months.
There are 14 other peers that have a rating on VRTX. Out of the 14 peers that are also analyzing VRTX, 1 agrees with Brian's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Joseph Stringer of "Needham" Reiterated at Hold on, Tuesday, May 7th, 2024
These are the ratings of the 13 analyists that currently disagree with Brian
- Evan Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $500 on, Friday, May 31st, 2024
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $462 on, Tuesday, May 7th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $456 on, Tuesday, May 7th, 2024
- Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $450 on, Thursday, April 18th, 2024
- Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $466 on, Wednesday, April 17th, 2024
- Hartaj Singh of "Oppenheimer" Maintained at Buy and Held Target at $500 on, Monday, April 15th, 2024
- Whitney Ijem of "Canaccord Genuity" Maintained at Strong Sell and Held Target at $371 on, Friday, April 12th, 2024
- Liisa Bayko of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $438 on, Thursday, April 11th, 2024
- Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $440 on, Tuesday, February 20th, 2024
- Andy Chen of "Wolfe Research" Initiated at Buy on, Thursday, February 15th, 2024
- Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $450 on, Tuesday, February 6th, 2024
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $472 on, Tuesday, February 6th, 2024
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $540 on, Tuesday, February 6th, 2024
Contributing Sources